出品 | 妙投APP作者 | 段明珠头图 | AI生成“顶流”张坤正在遭遇猛烈的反噬。

In the latest trading session, Novo Nordisk (NVO) closed at $80.57, marking a -0.57% move from the previous day.

2025年1月22日，制药公司诺和诺德（NVO）成交额为4.78亿美元，在当日美股中排第205名，成交额较昨日减少26.54%，当日成交量为590.44万。 诺和诺德（NVO）于2025年1月22日跌0.57%，报80.57美元，该股过去5个交易日跌2.83%，整个1月跌6.34%，年初至今跌6.34%，过去52周跌23.54%。

IMMvention and Novo Nordisk form a partnership to co-develop oral therapies for sickle cell disease, focusing on BACH1 ...

Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and ...

Shares of Novo Nordisk and Eli Lilly gain following study results that show GLP-1 drugs cut the risk of heart and kidney ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co ...

IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novo ...

A man has appeared in court charged with child cruelty after a toddler was found injured at a property in Surrey. Officers ...